High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease

Steve Pedrini1, Pratishtha Chatterjee1,2, Eugene Hone1

  • 1Sarich Neurosciences Research Institute, Edith Cowan University, Nedlands, WA, Australia.

Journal of Neurochemistry
|September 5, 2020
PubMed

Insights

High-density lipoproteins (HDL) remove excess cholesterol and possess anti-oxidant and anti-inflammatory properties. This review explores HDL protein cargo

Area of Science:

  • Biochemistry
  • Neuroscience
  • Cardiovascular Biology

Background:

  • High-density lipoproteins (HDL) are crucial for reverse cholesterol transport, moving excess cholesterol from peripheral tissues to the liver for elimination.
  • Beyond cholesterol transport, HDL possesses significant anti-oxidant and anti-inflammatory properties attributed to its associated proteins, termed 'protein cargo'.
  • The composition and function of HDL protein cargo have been analyzed in various health and disease states.

Purpose of the Study:

  • To review the formation, remodeling, and catabolism pathways of HDL.
  • To investigate the potential role of HDL protein cargo in the pathogenesis of Alzheimer's disease.

Main Methods:

  • Literature review of HDL metabolism and protein cargo analysis.
  • Exploration of mass spectrometry data from healthy and diseased individuals.
  • Analysis of existing research on HDL function and Alzheimer's disease.

Main Results:

  • HDL's multifaceted roles extend beyond cholesterol removal, including vital protective functions mediated by its protein cargo.
  • Alterations in HDL composition and protein cargo may be implicated in disease processes.
  • Specific HDL protein cargo components could influence neuroinflammation and neurodegeneration.

Conclusions:

  • HDL's protein cargo represents a significant area of investigation for understanding its diverse physiological roles.
  • Further research into HDL protein cargo may reveal novel therapeutic targets for Alzheimer's disease.
  • The interplay between HDL, its protein cargo, and neurodegenerative processes warrants detailed examination.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
635
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
560
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
226
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
509